20
Jul
As Alzheimer’s disease continues to affect millions worldwide and effective treatments remain limited, scientists are exploring a bold new direction: repurposing cancer medications. Research is shedding light on the possibility that drugs originally developed to treat tumors might help slow, or even reverse, the cognitive decline associated with Alzheimer’s. This innovative strategy aims to accelerate treatment development and offer new hope for patients in need.The idea behind this approach is compelling: many cancer therapies already approved for safety in humans can be fast‑tracked into Alzheimer’s clinical trials. These drugs are being investigated for their ability to target biological processes implicated…